Rhythm Pharmaceuticals In... (RYTM)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
57.25
0.73 (1.29%)
At close: Jan 28, 2025, 3:19 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
PE Ratio | -14.36 | -8.29 | -7.28 | -10.04 | -6.21 | -11.25 | -11.44 | -19.4 | -45.33 | -47.11 | -70.37 | -83.18 |
PS Ratio | 34.24 | 64.21 | 156.95 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 15.62 | 5.74 | 1.74 | 7.88 | 2.98 | 3.38 | 2.66 | 68.78 | 15.68 | -854.44 | -26.25 | -41.56 |
P/FCF Ratio | -19.47 | -8.54 | -3.27 | -10.74 | -6.63 | -13.28 | -13.03 | -20.67 | -71.76 | -40.74 | -78.72 | -84.58 |
P/OCF Ratio | -19.47 | -8.75 | -3.39 | -10.76 | -6.81 | -13.43 | -13.09 | -21.62 | -71.93 | -40.74 | -78.72 | -84.58 |
OCF/S Ratio | -1.76 | -7.34 | -46.29 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 5.43 | 8.83 | 7.10 | 10.10 | 12.38 | 19.05 | 22.42 | 2.36 | 6.73 | 0.35 | 5.93 | 7.54 |
Current Ratio | 5.58 | 8.90 | 7.10 | 10.10 | 12.38 | 19.05 | 22.42 | 2.36 | 6.73 | 0.35 | 5.93 | 7.54 |
Asset Turnover | 0.23 | 0.06 | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -13.27 | -34.45 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -1.09 | -0.69 | -0.24 | -0.79 | -0.48 | -0.3 | -0.23 | -3.55 | -0.35 | 18.14 | 0.37 | 0.50 |
Return on Assets (ROA) | -0.56 | -0.48 | -0.21 | -0.7 | -0.44 | -0.28 | -0.22 | -2.1 | -0.3 | -33.47 | -1.18 | -0.96 |
Return on Capital (ROIC) | -0.66 | -0.52 | -0.59 | -0.81 | -0.51 | -0.32 | -0.22 | -3.4 | -0.33 | 18.14 | -1.42 | -1.1 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 87.99% | 90.98% | 81.01% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -238.52% | -774.52% | -2.16K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -237.79% | -766.22% | -2.21K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -238.1% | -757.92% | -5.39K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | -175.91% | -751.79% | -4.80K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -217.58% | -738.28% | -2.17K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |